Study of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Recruiting

Phase 2

Denikitug, Nivolumab, FTD-TPI, BVZStudy of Denikitug (GS-1811) Given Alone or With Nivolumab or With Chemotherapy in Adults With Advanced Colorectal Cancer

Sponsor:

Gilead Sciences

Code:

NCT07527858

Conditions

Advanced Microsatellite Stable Colorectal Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Denikitug

Nivolumab

Bevacizumab

Trifluridine-Tipiracil

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-27. This information was provided to ClinicalTrials.gov by Gilead Sciences on 2026-06-12.